SCHEMBL7070868

SCHEMBL7070868

COc1ccccc1-c1sccc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 3/20 0.51
HTT P42858 1/20 0.49
GPR35 Q9HC97 3/20 0.48
KDM4E B2RXH2 4/20 0.48
HPGD P15428 4/20 0.48
ALDH1A1 P00352 3/20 0.48
HSD17B10 Q99714 3/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.45
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
KMT2A Q03164 1/20 0.43
CLCN2 P51788 1/20 0.42
APP P05067 1/20 0.42
HPGDS O60760 1/20 0.41
EIF4E P06730 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22261529 0.84 HTT (0.49) DHODHHTTGPR35KDM4EHPGD
SCHEMBL5924825 0.79 TDP1 (0.46) DHODHHTTGPR35KDM4EHPGD
SCHEMBL27785956 0.79 MYC (0.50) KDM4EHPGDALDH1A1HSD17B10TDP1
SCHEMBL15517040 0.78 GPR35 (0.57) DHODHHTTGPR35KDM4EHPGD
SCHEMBL19320865 0.78 MAPK1 (0.40) DHODHKDM4ETDP1L3MBTL1KMT2A
SCHEMBL14397485 0.78 PRNP (0.46) KDM4EHPGDALDH1A1HSD17B10TDP1
SCHEMBL7131872 0.77 KDM4E (0.55) KDM4EALDH1A1
SCHEMBL7075388 0.77 ALDH1A1 (0.48) KDM4EHPGDALDH1A1HSD17B10TDP1
SCHEMBL27943872 0.76 APP (0.50) KDM4EALDH1A1HSD17B10TDP1L3MBTL1
SCHEMBL536179 0.76 HTT (0.62) HTTGPR35KDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003051368-A1 N-AROYL CYCLIC AMINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2003-06-26 WO disclosed